Evonik Industries（EVK）株式概要エボニック インダストリーズ社は、アジア太平洋、ヨーロッパ、中東、アフリカ、中南米、北米で特殊化学品を生産しています。 詳細EVK ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長2/6過去の実績3/6財務の健全性5/6配当金4/6報酬当社が推定した公正価値より61.3%で取引されている 収益は年間17.21%増加すると予測されています 過去1年間で収益は19.4%増加しました リスク分析財務結果に影響を与える大きな一時的項目 5.72%の配当は利益で十分にカバーされていない すべてのリスクチェックを見るEVK Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCHF Current PriceCHF 16.1315.2% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-465m18b2016201920222025202620282031Revenue €15.5bEarnings €292.5mAdvancedSet Fair ValueView all narrativesFeatured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.4% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.5kusers have viewed this narrative40users have liked this narrative1users have commented on this narrative283users have followed this narrativeRead narrativeEvonik Industries AG 競合他社EMS-CHEMIE HOLDINGSymbol: SWX:EMSNMarket cap: CHF 15.8bSikaSymbol: SWX:SIKAMarket cap: CHF 23.5bGivaudanSymbol: SWX:GIVNMarket cap: CHF 25.6bAmrizeSymbol: SWX:AMRZMarket cap: CHF 23.5b価格と性能株価の高値、安値、推移の概要Evonik Industries過去の株価現在の株価€16.1352週高値€14.0452週安値€14.02ベータ0.541ヶ月の変化7.61%3ヶ月変化n/a1年変化n/a3年間の変化-55.06%5年間の変化-53.91%IPOからの変化-49.23%最新ニュースお知らせ • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.お知らせ • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026お知らせ • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026お知らせ • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.最新情報をもっと見るRecent updatesお知らせ • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.お知らせ • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026お知らせ • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026お知らせ • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.お知らせ • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025お知らせ • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of Swiss dividend payers (4.1%). Higher than average of industry peers (1.6%).Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance.お知らせ • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.Reported Earnings • Mar 05Full year 2023 earnings released: €1.00 loss per share (vs €1.16 profit in FY 2022)Full year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.お知らせ • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Reported Earnings • Aug 11Second quarter 2023 earnings released: €0.58 loss per share (vs €0.64 profit in 2Q 2022)Second quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.お知らせ • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024お知らせ • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).お知らせ • Jun 09RAG Stiftung Not in Hurry to Cut Evonik StakeRAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung.Upcoming Dividend • May 25Upcoming dividend of €1.17 per share at 5.9% yieldEligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of Swiss dividend payers (4.4%). Higher than average of industry peers (4.0%).Reported Earnings • May 10First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022)First quarter 2023 results: EPS: €0.10 (down from €0.67 in 1Q 2022). Revenue: €4.01b (down 11% from 1Q 2022). Net income: €47.0m (down 85% from 1Q 2022). Profit margin: 1.2% (down from 7.0% in 1Q 2022). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 8% per year, which means it is tracking significantly ahead of earnings growth.Reported Earnings • Mar 03Full year 2022 earnings released: EPS: €1.16 (vs €1.61 in FY 2021)Full year 2022 results: EPS: €1.16 (down from €1.61 in FY 2021). Revenue: €18.5b (up 24% from FY 2021). Net income: €539.0m (down 28% from FY 2021). Profit margin: 2.9% (down from 5.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 8% per year.お知らせ • Oct 12+ 2 more updatesEvonik Industries AG to Report Q2, 2023 Results on Aug 04, 2023Evonik Industries AG announced that they will report Q2, 2023 results on Aug 04, 2023Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: €0.64 (vs €0.48 in 2Q 2021)Second quarter 2022 results: EPS: €0.64 (up from €0.48 in 2Q 2021). Revenue: €4.77b (up 31% from 2Q 2021). Net income: €297.0m (up 34% from 2Q 2021). Profit margin: 6.2% (up from 6.1% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 1.9% compared to a 13% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.Upcoming Dividend • May 19Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 26 May 2022. Payment date: 31 May 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of Swiss dividend payers (3.9%). Higher than average of industry peers (1.6%).Reported Earnings • May 06First quarter 2022 earnings released: EPS: €0.67 (vs €0.41 in 1Q 2021)First quarter 2022 results: EPS: €0.67 (up from €0.41 in 1Q 2021). Revenue: €4.50b (up 34% from 1Q 2021). Net income: €314.0m (up 63% from 1Q 2021). Profit margin: 7.0% (up from 5.7% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 2.1%, compared to a 10% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 5% per year.Reported Earnings • Mar 05Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: €1.61 (up from €1.05 in FY 2020). Revenue: €15.0b (up 23% from FY 2020). Net income: €748.0m (up 53% from FY 2020). Profit margin: 5.0% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 2.9%, compared to a 11% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 9% per year, which means it is tracking significantly ahead of earnings growth.お知らせ • Mar 04Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023Evonik Industries AG announced that they will report Q4, 2022 results on Mar 02, 2023Reported Earnings • Nov 06Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €3.87b (up 33% from 3Q 2020). Net income: €231.0m (up 55% from 3Q 2020). Profit margin: 6.0% (up from 5.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €3.64b (up 29% from 2Q 2020). Net income: €221.0m (up 77% from 2Q 2020). Profit margin: 6.1% (up from 4.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.Upcoming Dividend • May 27Upcoming dividend of €1.15 per shareEligible shareholders must have bought the stock before 03 June 2021. Payment date: 08 June 2021. Trailing yield: 3.9%. Within top quartile of Swiss dividend payers (3.6%). Higher than average of industry peers (1.3%).Reported Earnings • May 08First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €3.36b (up 3.5% from 1Q 2020). Net income: €193.0m (up 42% from 1Q 2020). Profit margin: 5.7% (up from 4.2% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.Reported Earnings • Mar 05Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €12.2b (down 6.9% from FY 2019). Net income: €489.0m (down 35% from FY 2019). Profit margin: 4.0% (down from 5.7% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.Analyst Estimate Surprise Post Earnings • Mar 05Revenue beats expectationsRevenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 5.8%, compared to a 7.3% growth forecast for the Chemicals industry in Switzerland.Is New 90 Day High Low • Jan 22New 90-day high: CHF35.00The company is up 23% from its price of CHF28.48 on 23 October 2020. The Swiss market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF69.37 per share.Is New 90 Day High Low • Jan 07New 90-day high: CHF31.00The company is up 9.0% from its price of CHF28.47 on 09 October 2020. The Swiss market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF60.96 per share.Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 3.9%, compared to a 3.1% growth forecast for the Chemicals industry in Switzerland.Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS €0.32The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: €2.92b (down 9.7% from 3Q 2019). Net income: €149.0m (down 2.6% from 3Q 2019). Profit margin: 5.1% (up from 4.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 8% per year.株主還元EVKCH ChemicalsCH 市場7D2.2%1.2%2.3%1Yn/a-21.9%9.5%株主還元を見る業界別リターン: EVKがSwiss Chemicals業界に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。リターン対市場: EVK Swiss市場に対してどのようなパフォーマンスを示したかを判断するにはデータが不十分です。価格変動Is EVK's price volatile compared to industry and market?EVK volatilityEVK Average Weekly Movement4.2%Chemicals Industry Average Movement5.0%Market Average Movement4.6%10% most volatile stocks in CH Market8.4%10% least volatile stocks in CH Market2.3%安定した株価: EVK 、 Swiss市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 過去 1 年間のEVKのボラティリティの変化を判断するには データが不十分です。会社概要設立従業員CEO（最高経営責任者ウェブサイト184729,852Christian Kullmannevonik.comエボニック インダストリーズ社はアジア太平洋、ヨーロッパ、中東、アフリカ、中南米、北米で特殊化学品を生産している。スペシャリティアディティブス、ニュートリション＆ケア、スマートマテリアルズ、パフォーマンスマテリアルズ、テクノロジー＆インフラストラクチャーの各セグメントで事業を展開している。特殊添加剤事業では、ポリウレタン用添加剤、塗料、コーティング剤、印刷インキ用添加剤、艶消し剤、ヒュームドシリカ、特殊樹脂、コーティング剤、接着剤、複合材用イソホロン硬化剤、エポキシ硬化剤、建設機械・自動車用潤滑油塗料用流動点降下剤、粘度指数向上剤などを提供している。ニュートリション＆ケア事業では、動物栄養産業向けのD-l-メチオニンおよびリジン、アミノ酸およびペプチド、医薬品有効成分、整形外科および医療用途向けの生体適合性および生体吸収性材料、化粧品および洗剤産業向けのシステムソリューションを提供している。スマートマテリアルズ部門では、ヒュームドシリカ、沈殿シリカ、シランなどの無機材料、製紙・繊維産業用の過酸化物、合成用特殊触媒、アルコキシド、ポリマイド12、ポリマーフォーム、特殊ポリブタジエン、ポリエステルなどのポリマー製品、アルコキシド、メンブレンなどを提供している。機能材料部門は、自動車産業で使用されるブタジエン、MTBE、ブテン-1、イソノナノール、DINPからなるC4誘導体、紙おむつや衛生用品用の高吸水性製品を提供している。テクノロジー＆インフラストラクチャー部門は、エネルギー管理、総合プラントサポート＆メンテナンス、プロセス安全＆エンジニアリング、パイプライン、輸送管理、物流安全、化学生産用デジタルソリューション、戦略的立地開発サービスを提供している。同社は1873年に設立され、ドイツのエッセンに本社を置いている。もっと見るEvonik Industries AG 基礎のまとめEvonik Industries の収益と売上を時価総額と比較するとどうか。EVK 基礎統計学時価総額CHF 7.45b収益（TTM）CHF 242.45m売上高(TTM)CHF 12.87b30.7xPER（株価収益率0.6xP/SレシオEVK は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計EVK 損益計算書（TTM）収益€14.07b売上原価€10.61b売上総利益€3.46bその他の費用€3.20b収益€265.00m直近の収益報告Dec 31, 2025次回決算日May 08, 2026一株当たり利益（EPS）0.57グロス・マージン24.59%純利益率1.88%有利子負債／自己資本比率36.8%EVK の長期的なパフォーマンスは？過去の実績と比較を見る配当金5.7%現在の配当利回り176%配当性向EVK 配当は確実ですか？EVK 配当履歴とベンチマークを見るEVK 、いつまでに購入すれば配当金を受け取れますか？Evonik Industries 配当日配当落ち日Jun 04 2026配当支払日Jun 08 2026配当落ちまでの日数27 days配当支払日までの日数31 daysEVK 配当は確実ですか？EVK 配当履歴とベンチマークを見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/06 20:20終値2026/05/06 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Evonik Industries AG 13 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。30 アナリスト機関Anil ShenoyBarclaysAndreas HeineBarclaysSebastian BrayBerenberg27 その他のアナリストを表示
Featured narrative•Materials opportunityUpside Gold2 months ago author updated this narrativeSTFair Value from stuart_robertsCA$5.0768.4% 割安 内在価値ディスカウントAn Undervalued 3.3Moz Gold Project in CanadaKey takeaways Upside Gold is developing the Kena Gold Project, near the town of Nelson in the Kootenays region of southern British Columbia. Kena hosts a historical gold resource of 3.33 million ounces (561,000 ounces Indicated and 2.77 million ounces Inferred) across a 10,200-hectare land package.Read full narrative14.5kusers have viewed this narrative40users have liked this narrative1users have commented on this narrative283users have followed this narrativeRead narrative
お知らせ • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.
お知らせ • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026
お知らせ • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026
お知らせ • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.
お知らせ • Apr 17Evonik Industries AG, Annual General Meeting, Jun 03, 2026Evonik Industries AG, Annual General Meeting, Jun 03, 2026, at 10:00 W. Europe Standard Time.
お知らせ • Feb 06Evonik Industries AG announces Annual dividend, payable on June 08, 2026Evonik Industries AG announced Annual dividend of EUR 1.0000 per share payable on June 08, 2026, ex-date on June 04, 2026 and record date on June 05, 2026.
お知らせ • Nov 06+ 2 more updatesEvonik Industries AG to Report Q1, 2026 Results on May 08, 2026Evonik Industries AG announced that they will report Q1, 2026 results on May 08, 2026
お知らせ • Oct 06Evonik Industries AG to Report Q4, 2025 Results on Mar 04, 2026Evonik Industries AG announced that they will report Q4, 2025 results on Mar 04, 2026
お知らせ • Sep 26Evonik Industries AG Provides Earnings Guidance for the Third Quarter of 2025Evonik Industries AG provided earnings guidance for the third quarter of 2025. The company expects revenue to be around €3.4 billion in the third quarter of 2025, compared to €3.8 billion in third quarter of 2024.
お知らせ • Mar 06Evonik Industries AG announces Annual dividend, payable on June 02, 2025Evonik Industries AG announced Annual dividend of EUR 1.1700 per share payable on June 02, 2025, ex-date on May 29, 2025 and record date on May 30, 2025.
お知らせ • Sep 20Evonik Industries AG to Report Q1, 2025 Results on May 12, 2025Evonik Industries AG announced that they will report Q1, 2025 results on May 12, 2025
お知らせ • Sep 04+ 1 more updateEvonik Industries AG to Report Q2, 2025 Results on Aug 01, 2025Evonik Industries AG announced that they will report Q2, 2025 results on Aug 01, 2025
Reported Earnings • Aug 02Second quarter 2024 earnings released: €0.01 loss per share (vs €0.58 loss in 2Q 2023)Second quarter 2024 results: €0.01 loss per share (improved from €0.58 loss in 2Q 2023). Revenue: €3.93b (up 1.1% from 2Q 2023). Net loss: €5.00m (loss narrowed 98% from 2Q 2023). Revenue is forecast to grow 2.8% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 86 percentage points per year, which is a significant difference in performance.
Upcoming Dividend • May 29Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 05 June 2024. Payment date: 07 June 2024. The company is not currently making a profit but it is cash flow positive. Trailing yield: 5.8%. Within top quartile of Swiss dividend payers (4.1%). Higher than average of industry peers (1.6%).
Reported Earnings • May 09First quarter 2024 earnings released: EPS: €0.33 (vs €0.10 in 1Q 2023)First quarter 2024 results: EPS: €0.33 (up from €0.10 in 1Q 2023). Revenue: €3.80b (down 5.2% from 1Q 2023). Net income: €156.0m (up 232% from 1Q 2023). Profit margin: 4.1% (up from 1.2% in 1Q 2023). Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 20+ 1 more updateEvonik Industries AG, Annual General Meeting, May 28, 2025Evonik Industries AG, Annual General Meeting, May 28, 2025.
Reported Earnings • Mar 05Full year 2023 earnings released: €1.00 loss per share (vs €1.16 profit in FY 2022)Full year 2023 results: €1.00 loss per share (down from €1.16 profit in FY 2022). Revenue: €15.3b (down 17% from FY 2022). Net loss: €465.0m (down 186% from profit in FY 2022). Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 5.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 60% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Mar 05International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik.International Chemical Investors S.E. agreed to acquire Superabsorbents business of Evonik on March 4, 2024. The business to be sold generated sales of €892 million in 2023, with adjusted EBITDA in the mid double-digit million euro range. The final transfer of the business is planned for mid-2024 following approval by the relevant competition authorities.
お知らせ • Jan 16Lanxess Reportedly Seeks to Sell Polyurethane OpsLANXESS Aktiengesellschaft (XTRA:LXS) has initiated a process to sell its polyurethane business, which could be valued at between EUR 500 million (USD 547.2 million) and EUR 600 million, German paper Handelsblatt reported on January 15, 2024. The company has engaged Deutsche Bank to search for a buyer, Handelsblatt said, citing people familiar with the matter. Chemical companies such as Evonik Industries AG (XTRA:EVK), Stockmeier, or Plixxent, are considered possible interested parties. With the sale, Lanxess aims to completely exit the plastics market as the company has transformed into a producer of ingredients for food, cosmetics, and pharmaceuticals.
Reported Earnings • Nov 08Third quarter 2023 earnings released: €0.21 loss per share (vs €0.46 profit in 3Q 2022)Third quarter 2023 results: €0.21 loss per share (down from €0.46 profit in 3Q 2022). Revenue: €3.77b (down 23% from 3Q 2022). Net loss: €96.0m (down 145% from profit in 3Q 2022). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 42% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 11Second quarter 2023 earnings released: €0.58 loss per share (vs €0.64 profit in 2Q 2022)Second quarter 2023 results: €0.58 loss per share (down from €0.64 profit in 2Q 2022). Revenue: €3.89b (down 19% from 2Q 2022). Net loss: €270.0m (down 191% from profit in 2Q 2022). Revenue is forecast to grow 2.0% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has fallen by 18% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
お知らせ • Aug 10+ 3 more updatesEvonik Industries AG to Report Q1, 2024 Results on May 08, 2024Evonik Industries AG announced that they will report Q1, 2024 results on May 08, 2024
お知らせ • Jul 12Evonik Industries AG Revises Financial Guidance for the Full Year 2023Evonik Industries AG revised financial guidance for the full year 2023. The sales outlook is adjusted to a range between EUR 14 billion and EUR 16 billion (previously: EUR 17 billion to EUR 19 billion).
お知らせ • Jun 09RAG Stiftung Not in Hurry to Cut Evonik StakeRAG-Stiftung is not in a hurry to reduce its stake in chemicals firm Evonik Industries AG (XTRA:EVK) as the foundation is not under financial pressure, RAG chairman Bernd Toenjes said at a press conference as quotes by German paper Frankfurter Allgemeine Zeitung (FAZ). RAG Stiftung, which owns 54.9% in the chemicals company, plans to cut its stake to a blocking minority in the future. The shareholding may fall below the majority threshold soon. According to Toenjes, a convertible bond is due in 2024, providing an opportunity to reach 50% by the end of 2024. For the moment, Evonik remains one of the most important assets for RAG Stiftung.
Upcoming Dividend • May 25Upcoming dividend of €1.17 per share at 5.9% yieldEligible shareholders must have bought the stock before 01 June 2023. Payment date: 05 June 2023. The company is paying out more than 100% of its profits and is paying out 81% of its cash flow. Trailing yield: 5.9%. Within top quartile of Swiss dividend payers (4.4%). Higher than average of industry peers (4.0%).
Reported Earnings • May 10First quarter 2023 earnings released: EPS: €0.10 (vs €0.67 in 1Q 2022)First quarter 2023 results: EPS: €0.10 (down from €0.67 in 1Q 2022). Revenue: €4.01b (down 11% from 1Q 2022). Net income: €47.0m (down 85% from 1Q 2022). Profit margin: 1.2% (down from 7.0% in 1Q 2022). Revenue is forecast to grow 3.2% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 8% per year, which means it is tracking significantly ahead of earnings growth.
Reported Earnings • Mar 03Full year 2022 earnings released: EPS: €1.16 (vs €1.61 in FY 2021)Full year 2022 results: EPS: €1.16 (down from €1.61 in FY 2021). Revenue: €18.5b (up 24% from FY 2021). Net income: €539.0m (down 28% from FY 2021). Profit margin: 2.9% (down from 5.0% in FY 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.6% p.a. on average during the next 3 years, compared to a 6.5% growth forecast for the Chemicals industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 8% per year.
お知らせ • Oct 12+ 2 more updatesEvonik Industries AG to Report Q2, 2023 Results on Aug 04, 2023Evonik Industries AG announced that they will report Q2, 2023 results on Aug 04, 2023
Reported Earnings • Aug 11Second quarter 2022 earnings released: EPS: €0.64 (vs €0.48 in 2Q 2021)Second quarter 2022 results: EPS: €0.64 (up from €0.48 in 2Q 2021). Revenue: €4.77b (up 31% from 2Q 2021). Net income: €297.0m (up 34% from 2Q 2021). Profit margin: 6.2% (up from 6.1% in 2Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is expected to shrink by 1.9% compared to a 13% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 13% per year whereas the company’s share price has increased by 8% per year.
Upcoming Dividend • May 19Upcoming dividend of €1.17 per shareEligible shareholders must have bought the stock before 26 May 2022. Payment date: 31 May 2022. Payout ratio is a comfortable 63% and this is well supported by cash flows. Trailing yield: 4.5%. Within top quartile of Swiss dividend payers (3.9%). Higher than average of industry peers (1.6%).
Reported Earnings • May 06First quarter 2022 earnings released: EPS: €0.67 (vs €0.41 in 1Q 2021)First quarter 2022 results: EPS: €0.67 (up from €0.41 in 1Q 2021). Revenue: €4.50b (up 34% from 1Q 2021). Net income: €314.0m (up 63% from 1Q 2021). Profit margin: 7.0% (up from 5.7% in 1Q 2021). The increase in margin was driven by higher revenue. Over the next year, revenue is forecast to grow 2.1%, compared to a 10% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 7% per year whereas the company’s share price has increased by 5% per year.
Reported Earnings • Mar 05Full year 2021 earnings: EPS in line with analyst expectations despite revenue beatFull year 2021 results: EPS: €1.61 (up from €1.05 in FY 2020). Revenue: €15.0b (up 23% from FY 2020). Net income: €748.0m (up 53% from FY 2020). Profit margin: 5.0% (up from 4.0% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 2.1%. Over the next year, revenue is forecast to grow 2.9%, compared to a 11% growth forecast for the industry in Switzerland. Over the last 3 years on average, earnings per share has increased by 1% per year but the company’s share price has increased by 9% per year, which means it is tracking significantly ahead of earnings growth.
お知らせ • Mar 04Evonik Industries AG to Report Q4, 2022 Results on Mar 02, 2023Evonik Industries AG announced that they will report Q4, 2022 results on Mar 02, 2023
Reported Earnings • Nov 06Third quarter 2021 earnings released: EPS €0.49 (vs €0.32 in 3Q 2020)The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: €3.87b (up 33% from 3Q 2020). Net income: €231.0m (up 55% from 3Q 2020). Profit margin: 6.0% (up from 5.1% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 6% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Reported Earnings • Aug 06Second quarter 2021 earnings released: EPS €0.48 (vs €0.26 in 2Q 2020)The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €3.64b (up 29% from 2Q 2020). Net income: €221.0m (up 77% from 2Q 2020). Profit margin: 6.1% (up from 4.4% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 2% per year, which means it has not declined as severely as earnings.
Upcoming Dividend • May 27Upcoming dividend of €1.15 per shareEligible shareholders must have bought the stock before 03 June 2021. Payment date: 08 June 2021. Trailing yield: 3.9%. Within top quartile of Swiss dividend payers (3.6%). Higher than average of industry peers (1.3%).
Reported Earnings • May 08First quarter 2021 earnings released: EPS €0.41 (vs €0.29 in 1Q 2020)The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €3.36b (up 3.5% from 1Q 2020). Net income: €193.0m (up 42% from 1Q 2020). Profit margin: 5.7% (up from 4.2% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings.
Reported Earnings • Mar 05Full year 2020 earnings releasedThe company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: €12.2b (down 6.9% from FY 2019). Net income: €489.0m (down 35% from FY 2019). Profit margin: 4.0% (down from 5.7% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
Analyst Estimate Surprise Post Earnings • Mar 05Revenue beats expectationsRevenue exceeded analyst estimates by 0.3%. Over the next year, revenue is forecast to grow 5.8%, compared to a 7.3% growth forecast for the Chemicals industry in Switzerland.
Is New 90 Day High Low • Jan 22New 90-day high: CHF35.00The company is up 23% from its price of CHF28.48 on 23 October 2020. The Swiss market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF69.37 per share.
Is New 90 Day High Low • Jan 07New 90-day high: CHF31.00The company is up 9.0% from its price of CHF28.47 on 09 October 2020. The Swiss market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CHF60.96 per share.
Analyst Estimate Surprise Post Earnings • Nov 05Revenue beats expectationsRevenue exceeded analyst estimates by 0.1%. Over the next year, revenue is forecast to grow 3.9%, compared to a 3.1% growth forecast for the Chemicals industry in Switzerland.
Reported Earnings • Nov 05Third quarter 2020 earnings released: EPS €0.32The company reported a soft third quarter result with weaker earnings and revenues, although profit margins were improved. Third quarter 2020 results: Revenue: €2.92b (down 9.7% from 3Q 2019). Net income: €149.0m (down 2.6% from 3Q 2019). Profit margin: 5.1% (up from 4.7% in 3Q 2019). The increase in margin was driven by lower expenses. Over the last 3 years on average, earnings per share has fallen by 6% per year whereas the company’s share price has fallen by 8% per year.
